Advertisement #1
Home Tags Folate receptor alpha

Tag: folate receptor alpha

Mirvetuximab Soravtansine Improves Survival in Women With Recurrent Ovarian Cancer

Editorial Team -
Attendees networking during during the American Society of Clinical Oncology (ASCO) Annual Meeting. Courtesy: ? ASCO/Danny Morton

SORAYA Shows Consistent Safety Profile for Mirvetuximab Soravtansine in Ovarian Cancer

Danielle Garcia -
Thoughtful young women suffering from ovarian cancer.

Folate Receptor Alpha-targeting Antibody-drug Conjugate gets FDA Fast Track Designation

Danielle Garcia -
The American Association for Cancer Research (AACR) Annual Meeting in pre-COVID19 Days: New Orleans, LA - The AACR 2016 Annual Meeting. Photo courtesy AACR/Scott Morgan.

STRO-002 Shows Encouraging Results in Phase I Trial in Treatment of...

Peter Hofland -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

ESMO 2019: FORWARD I Study Evaluating Mirvetuximab Soravtansine Did Not Meet...

Peter Hofland -

LATEST NEWS

Advertisment #12
© 2001 - 2023 Sunvalley Communication, LLC. All Rights Reserved.

X